LATEST CONTENT

RPA
SSON asks implementation experts from multi-nationals what they are getting out of RPA
survey
Key findings on what's driving "radical performance"
December 9, 2016 by
security thumb
Bots are visible, traceable, and secure – so what's missing?
December 9, 2016 by Barbara Hodge, Editor

LATEST INDUSTRY REPORTS

Pharma IQ spoke to Mark Davison, Chief Executive Officer Blue Sphere Health Ltd to gain insight on his experience working with SME pharma & biotechs for serialisation. Also we spoke to Vetter pharma – a responsible CMO for their insight on how peer CMOs can scale the summit that is serialisation. Learn more »

September 20, 2016

Ahead of this year’s Early Access Programmes Europe conference, Pharma IQ expands its regulatory handbook to develop the industry’s awareness of the various compliance requirements that surround the implementation of these programmes Learn more »

September 15, 2016

Industry stakeholders have insisted that it could be a costly mistake to view serialisation as a project which only concerns engineering matters. As serialisation data is unique to the pack it requires not only the deployment of new treatment but also expanded staff investment and stakeholder engagement. Therefore, “To characterize it as an engineering issue is therefore to grossly underestimate its consequences, which touch virtually every business function in pharmaceutical manufacturing.” Learn more »

August 11, 2016

UPCOMING EVENTS

March 20 - 23, 2017
Shanghai, China
February 21 - 24, 2017
Hilton Munich City , Munich, Germany
March 27 - 29, 2017
Philadelphia
February 27 - 28, 2017
Germany
February 07 - 08, 2017
Berlin, Germany
February 15 - 16, 2017
Brussels, Belgium
January 30 - 01, 2017
Boston, MA
February 21 - 22, 2017
Hilton San Diego Mission Valley, San Diego, CA

LATEST WEBINARS

David
Case Study: Developing Predictive Liver Models from Pluripotent Stem Cells
Sign Up »
sheraz-gul
How to Reduce Late Stage Attrition in Drug Discovery
Sign Up »
Debby
The Utility of Advanced In Vitro Models in Toxicology and Disease Modeling
Sign Up »
gerd
Mechanisms of drug-induced liver injury and novel biomarkers for its assessment
Sign Up »
dona
Gain a Competitive Advantage: Answers to Your Top 3 Supply Chain Challenges
Sign Up »
Fedex

LATEST INTERVIEWS

GPC 2
Legal IQ spoke to Ligia Gata, IP Manager at Bioingenium, to discover the IP challenges faced by the Pharmaceutical industry in 2015. In this... Learn more »
June 28, 2016
Martin Thorley
In both a paper and electronic TMF environment, massive challenges delay the successful development, management and monitoring of an inspection-ready... Learn more »
May 10, 2015
Pharma IQ
Dr. Guido Claes, Director Master Data Management for Pharma R&D at Janssen Pharmaceuticals will be a key speaker at the upcoming... Learn more »
April 29, 2015

LATEST PODCASTS

Big data is turning up everywhere. In this Process Perspectives podcast, Kaare Buch Petersen, Information Architect in Global IT at Christen Hansen, a Denmark-based supplier of bioscience products to food and health industries, talks about how his company has been using big data in the development of their new products. Editor's note: read... Learn more »
July 2, 2014
The informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst, Senior Scientist at the Hershey's Company talks us through these changes and how the industry is moving away from robots towards more innovative methods including mobile apps. He also talks about the dangers of... Learn more »
March 24, 2014
The pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contract Manufacturing Director at Pepsico. Steve outlines where companies can go wrong in working with CMOs
March 12, 2014

Get the latest Pharma IQ news and Updates

Connect with your peers
Already a member? Sign In to complete your profile or Become a Member today!